CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VKTX — Viking Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,504,216
+$4,539,645 QoQ
Shares Held
730,690
-0.8% QoQ
Ownership
0.626%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 435 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. VKTX ranks #52 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in VKTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,504,216 | 730,690 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,964,571 | 736,465 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,636,378 | 700,295 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,335,766 | 697,708 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,276,630 | 727,420 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,192,312 | 711,897 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $29,320,956 | 728,652 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $45,304,446 | 715,597 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $35,594,889 | 671,475 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $68,796,688 | 838,984 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,435,758 | 775,699 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,472,092 | 765,320 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,210,417 | 259,742 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $610,522 | 36,668 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $272,280 | 28,966 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $78,787 | 28,966 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $128,506 | 44,466 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $589,230 | 196,410 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $815,699 | 177,326 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,080,756 | 172,095 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,027,518 | 171,539 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,052,827 | 166,455 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $873,117 | 155,083 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $904,119 | 155,347 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,164,256 | 161,478 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $786,956 | 168,153 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||